Product: CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. Marketed by: AbbVie Inc., North Chicago, IL 60064, Product of Germany. NDC 0032-1224-07.
Reason for recall: Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.
Recall initiated: 20140915
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated